To mimic the RA microenvironment, proinflammatory cytokines (TNF-α, IL-1β, and IL-6) and the immunostimulant lipopolysaccharide (LPS) were used to treat MH7A cells for 24 h. The gene discussed is IL6; the disease is rheumatoid arthritis.